Targeted tau clearance in 3xTg-AD mice resulted in a more noticeable cognitive improvement, whereas in 5xFAD mice, where tau pathology is less pronounced, cognitive enhancement was not as evident as that observed in those 3xTg-AD mice. This evidence concerns the gene MAPT and Alzheimer disease.